January 14, 2015
Daniel Fischler remembers the call. “When a doctor calls you at 10:30 on a Friday night, it’s not going to be good news.” He had undergone an MRI for a herniated disc, but when the test revealed a shadow on his left bowel, a CT was ordered. Then came the call from his doctor. “He told me that it was very likely a tumor. I was knocked out, shocked by the bad news.”
January 14, 2015
In 2011, Tricia Prestia was wearing a lot of hats. A wife, a mother and a busy women’s health nurse practitioner in Cary, Tricia drew on her training and experience as a cytologist - the person who studies cellular changes that may indicate cancer - in her nursing practice.
January 13, 2015
Researchers look at area around tumors to help personalize treatment for triple-negative breast cancer
January 13, 2015
The Duke Endowment awards $461,750 grant to UNC Lineberger’s Comprehensive Cancer Support Program.
January 13, 2015
The Duke Endowment awards $461,750 grant to UNC Lineberger’s Comprehensive Cancer Support Program.
January 12, 2015
Temitope Keku, MSPH, PhD has published a review in The American Journal of Physiology—Gastrointestinal and Liver Physiology titled “The Gastrointestinal Microbiota and Colorectal Cancer.” Coauthors include Drs. Santosh Dulal, April Deveaux, Biljana Jovov, and Xuesong Han. This article provides an overview on the role of resident gut microbiota in the development of human colorectal cancer and explores its association with diet and inflammation.
January 9, 2015
Ebix, Inc., today announced that the annual Ebix Charity Challenge, will be held in Greensboro, North Carolina on February 7, 2015. All proceeds from the 5th Annual Ebix Charity Challenge will benefit the UNC Lineberger Comprehensive Cancer Center, where America No. 1 John Isner’s mother, Karen, was successfully treated during her two battles with colon cancer.
January 8, 2015
UNC Lineberger members Joseph DeSimone, PhD and Jenny Ting, PhD, along with other researchers at the UNC-Chapel Hill and North Carolina State University have uncovered a novel approach to creating inhalable vaccines using nanoparticles that shows promise for targeting lung-specific diseases, such as influenza, pneumonia and tuberculosis. The findings, published in the Proceedings of the National Academy of Sciences, also have broad public health implications for improving the accessibility of vaccines.
January 7, 2015
Researchers at the UNC-Chapel Hill and North Carolina State University have uncovered a novel approach to creating inhalable vaccines using nanoparticles that shows promise for targeting lung-specific diseases, such as influenza, pneumonia and tuberculosis. The work was led by Cathy Fromen and Gregory Robbins, members of the DeSimone and Ting labs at UNC Lineberger, and reveals that a particle’s surface charge plays a key role in eliciting immune responses in the lung.
January 6, 2015
Carolina legend Danny Talbott performed at the highest level on both the football field and baseball diamond during his years as a Tar Heel. Since 2010, he’s been back in Chapel Hill, battling the toughest opponent he’s faced: multiple myeloma. He can’t imagine going anywhere else to do it.
